Autologous transfusion and other approaches to reduce allogeneic blood exposure

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 4, 2000, Pages 533-547

  Vamvakas, Eleftherios C ^a,b   Pineda, Alvaro A ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Autologous transfusion; Benefit; Cost effectiveness; Efficacy; Indications; Risk; Safety

Indexed keywords

ALLOGENEIC RESTRICTION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMODILUTION; HUMAN; IMMUNOMODULATION; INFECTION; INTERMETHOD COMPARISON; MALE; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SAFETY; TREATMENT OUTCOME;

EID: 0034522634     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2000.0098     Document Type: Article

References (67)

1. Transfusion Medicine: II. Blood conservation
2. Practice strategies for elective red blood cell transfusion
3. Autologous blood donation - Can we bank on it?
4. Cost-effectiveness of autologous blood donation
5. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting
6. The safety of preoperative autologous blood donation in the nonhospital setting
7. Severe outcomes of allogeneic and autologous blood donations: Frequency and characterization
8. Autologous blood donation: Hemodynamics in a high-risk population
9. Autologous blood: Always safer?
10. Preoperative autologous blood donation: Benefit or detriment? A mathematical analysis
11. Preoperative autologous blood donations before elective hysterectomy
12. Impact of autologous blood transfusions on patients undergoing radical prostatectomy using hypotensive anesthesia
13. Preoperative red cell production in patients undergoing weekly autologous blood donation
14. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients
15. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy
16. Limitations to storing adequate autologous blood prior to elective surgery
17. Long-term survival after blood transfusion
18. Crossover use of donated blood for autologous transfusions: Report of the Council on Scientific Affairs American, Medical Association
19. Autologous and designated donor programs
20. The cost-effectiveness of preoperative autologous blood donations
21. The cost-effectiveness of preoperative autologous blood donations for total hip and knee replacement
22. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures
23. Deleterious effects of transfusion-associated immunomodulation: Appraisal of the evidence and recommendations for prevention
24. Effect of blood transfusion on subsequent kidney transplants
25. Red blood cells for cancer patients
26. Perioperative blood transfusion and cancer recurrence: Meta-analysis for explanation
27. Differences in postoperative infection rates between patients receiving autologous and allogeneic blood transfusion: A meta-analysis of published randomized and non-randomized studies
28. Biologic effects of leukocytes present in transfused cellular blood products
29. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients
30. Peptide-mediated immunosuppression
31. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood
32. Detrimental effects of perioperative blood transfusion
33. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery
34. Blood transfusion and prognosis in colorectal cancer
35. Meta-analysis in clinical trials
36. The cost-effectiveness of autologous transfusion revisited: Implications of an increased risk of bacterial infection with allogeneic transfusion
37. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion
38. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells
39. Proposed mechanisms of the immunomodulatory effect of allogeneic blood transfusion
40. The cost-effectiveness of autologous transfusion revisited: Implications of an increased risk of bacterial infection with allogeneic transfusion
41. Consensus conference on autologous transfusion: Preoperative autologous donation
42. A point system for predicting the likelihood of blood transfusion after hip or knee arthroplasty
43. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy
44. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial
45. Erythropoietin therapy
46. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement
47. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopedic operation
48. Avoidance of allogeneic blood transfusion by treatment with recombinant human erythropoietin (epoietin beta) in patients undergoing open-heart surgery
49. Autologous transfusion, 3 years on: What is new? What has happened?
50. Guidelines for autologous transfusion: II. Perioperative hemodilution and cell salvage
51. Acute normovolemic hemodilution
52. Mathematical and computer modeling of acute normovolemic hemodilution
53. A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood
54. Intraoperative hemodilution is more cost-effective than preoperative autologous donation for patients undergoing procedures associated with a low risk for transfusion
55. Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method for autologous-blood procurement
56. Acute normovolemic hemodilution is a legitimate alternative to allogeneic blood transfusion
57. Consensus conference on autologous transfusion: Final consensus statement
58. Intraoperative blood salvage: A review
59. Intraoperative autotransfusion
60. Perioperative red cell salvage: A case for implementing the 1995 consensus statement
61. Intraoperative autologous blood transfusion
62. The efficacy of intraoperative autologous transfusion in orthopedic surgery: A regression analysis
63. Cost comparison of intraoperative autologous versus homologous transfusion
64. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: An analysis of cost and benefit
65. Cell saver and radical retropubic prostatectomy: Analysis of cost-effectiveness
66. A controlled trial of intraoperative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome
67. A randomized trial of intraoperative transfusion during aortic surgery